Policy Bulletins
The Policy Bulletins listed below represent our catalogue of medical and claim payment policies. If you are looking for a specific type of policy, choose a category from the menu on the right. You may also use the search function in the top menu to search for policies by word or phrase.
 
   


Policy #
Policy Bulletin Title
Show details for
08.00.62j
Abatacept (Orencia®) for Injection for Intravenous Use
Show details for
08.01.11e
Ado-Trastuzumab Emtansine (Kadcyla®)
08.00.69b
Agalsidase beta (Fabrazyme®)
08.01.22d
Alemtuzumab (Lemtrada®)
08.00.72h
Alglucosidase alfa (e.g., Lumizyme®)
08.00.91d
Alpha 1-Antitrypsin Therapy (e.g., Prolastin-C®, Aralast NP™, Glassia™, Zemaira™)
Show details for
08.01.41c
Aprepitant (Cinvanti™), Fosaprepitant Dimeglumine (Emend®), Granisetron (Sustol®), and Rolapitant (Varubi®)
08.01.35b
Asparaginase Erwinia Chrysanthemi (Erwinaze®)
08.00.99c
Belimumab (Benlysta®) for Intravenous Use
Show details for
08.00.66n
Bevacizumab (Avastin®) and Related Biosimilars For Oncologic Use
08.01.21c
Blinatumomab (Blincyto®)
08.00.73l
Bortezomib (Bortezomib for Injection, Velcade®)
Show details for
08.00.26w
Botulinum Toxin Agents
Show details for
08.01.13d
Brentuximab Vedotin (Adcetris®)
08.01.49a
Burosumab-twza (Crysvita®)
08.00.96d
Cabazitaxel (Jevtana®)
08.01.51
Canakinumab (Ilaris®)
08.01.05f
Carfilzomib (Kyprolis™)
08.01.39c
Cerliponase alfa (Brineura®)
Show details for
08.00.67l
Cetuximab (Erbitux®)
Show details for
08.01.43e
Chimeric Antigen Receptor (CAR) Therapy
08.00.92ab
Coagulation Factors
08.01.08d
Coverage of Prescription Oral Anticancer Drugs and/or Biologics as Provided Under the Company's Medical Benefit
08.01.29e
Daratumumab (Darzalex™)
Show details for
08.00.94m
Denosumab (Prolia®, Xgeva®), Romosozumab-aqqg (Evenity™)
08.01.24a
Deoxycholic Acid (Kybella™)
08.00.49e
Dofetilide (Tikosyn®) Use in the Inpatient Setting
08.01.37a
Drugs Used for the Maintenance Treatment of Opioid or Alcohol Use Disorder (e.g., Naltrexone Implants, Probuphine Implant, Sublocade Injection, Vivitrol Injection)
08.00.84g
Eculizumab (Soliris®) and Related Biosimilars, Ravulizumab-cwvz (Ultomiris®)
08.01.42a
Edaravone (Radicava™)
08.01.54b
Emapalumab-lzsg (Gamifant®)
08.00.43a
Enfortumab vedotin-ejfv (Padcev™)
08.00.51j
Enzyme Replacement for the Treatment of Gaucher's Disease
08.01.26c
Enzyme Replacement Therapy for Adenosine Deaminase Severe Combined Immune Deficiency (e.g., elapegademase-lvlr [Revcovi™)
08.00.70e
Enzyme Replacement Therapy for Mucopolysaccharidosis (e.g., Aldurazyme®, Elaprase®, Vimizim®, Naglazyme®, Mepsevii™, etc.)
Show details for
08.00.45a
Eptinezumab-jjmr (VYEPTI™)
Show details for
08.00.98e
Eribulin Mesylate (Halaven®)
08.00.75n
Erythropoiesis-Stimulating Agents (ESAs)
08.00.12a
Fam-trastuzumab deruxtecan-nxki (Enhertu®)
Show details for
08.01.15d
Golimumab (Simponi Aria®) Intravenous (IV) Injection
08.01.33b
Gonadotropin-Releasing Hormone Agonist (Eligard®, Lupron Depot®)
08.01.00g
Hydroxyprogesterone Caproate Injection as a Technique to Reduce the Risk of Preterm Birth in High-Risk Pregnancies
08.01.46a
Ibalizumab-uiyk (Trogarzo™)
Show details for
08.00.13w
Immune Globulin Intravenous (IVIG), Subcutaneous (SCIG)
08.00.22m
Immune Prophylaxis for Respiratory Syncytial Virus (RSV)
08.01.04v
Immunizations
Show details for
08.00.34n
Infliximab and Related Biosimilars
08.01.23f
Interleukin-5 (IL-5) Antagonist (e.g., Cinqair®, Nucala®) and IL-5 Receptor Antagonist (e.g., Fasenra®)
Show details for
08.00.74n
Intravitreal Injection of Vascular Endothelial Growth Factor (VEGF) Antagonists and Related Biosimilars
Show details for
08.01.01i
Ipilimumab (Yervoy®)
08.00.46
Isatuximab-irfc (Sarclisa®)
Show details for
08.01.40b
Lanreotide (Somatuline® Depot)
08.00.10b
Luspatercept–aamt (Reblozyl®)
08.01.57
Lutathera® (Lutetium Lu 177 Dotatate) (AmeriHealth Administrators)
08.01.52b
Mogamulizumab-kpkc (Poteligeo®)
08.01.53b
Moxetumomab Pasudotox-tdfk (Lumoxiti™)
08.00.64g
Natalizumab (Tysabri®)
Show details for
08.00.18m
Nutritional Formulas, Enteral Nutrition, Medical Foods, Low-Protein Modified Food Products, and Donated Breast Milk
08.01.38c
Ocrelizumab (Ocrevus®)
Show details for
08.01.10f
Octreotide Acetate (Sandostatin® LAR Depot)
08.00.88f
Ofatumumab (Arzerra®)
08.00.15f
Off-label Coverage for Prescription Drugs and/or Biologics
Show details for
08.00.55h
Omalizumab (Xolair®)
Show details for
08.00.90j
Paclitaxel Protein-bound Particles for Injectable Suspension (Albumin-bound)/(Abraxane® for Injectable Suspension)
08.01.50b
Patisiran (Onpattro™)
Show details for
08.01.32c
Pegfilgrastim (Neulasta®) and Related Biosimilars
Show details for
08.01.02e
Pegloticase (Krystexxa®)
Show details for
08.00.87f
Pemetrexed (Alimta®)
08.00.95d
Personalized Vaccines (e.g. Provenge®)
Show details for
08.01.07f
Pertuzumab (Perjeta®)
08.01.59b
Polatuzumab Vedotin-Piiq (Polivy™)
Show details for
08.01.20j
Programmed Death Receptor-1 (PD-1) Antagonists (e.g., Keytruda®, Opdivo®) and Programmed Death-Ligand 1 (PD-L1) Antagonists (e.g., Tecentriq®, Bavencio®, Imfinzi™)
Show details for
08.00.08j
Radioimmunotherapy with Ibritumomab Tiuxetan (Zevalin®) (AmeriHealth Administrators)
08.01.14e
Radium Ra 223 dichloride (Xofigo®) Injection (AmeriHealth Administrators)
08.01.25d
Ramucirumab (Cyramza®)
08.01.12b
Repository Corticotropin (H.P. Acthar® Gel Injection)
Show details for
08.00.50v
Rituximab (Rituxan®) Infusion and Related Biosimilars, and Rituximab/Hyaluronidase Human for Subcutaneous Injection (Rituxan Hycela®)
Show details for
08.01.60
Sacituzumab govitecan-hziy (TrodelvyTM)
08.01.28d
Sebelipase alfa (Kanuma®)
Show details for
08.00.78ae
Self-Administered Drugs
08.01.19f
Siltuximab (Sylvant®)
08.01.55c
Tagraxofusp-erzs (Elzonris™)
08.01.36e
Therapies for Spinal Muscular Atrophy Nusinersen (Spinraza®) and Onasemnogene abeparvovec-xioi (Zolgensma®)
08.01.48b
Tildrakizumab-asmn (Ilumya™)
Show details for
08.00.85i
Tocilizumab (Actemra®) for Intravenous Infusion
08.00.17h
Total Parenteral Nutrition (TPN) / Intradialytic Parenteral Nutrition (IDPN) / Intraperitoneal Parenteral Nutrition (IPN)
Show details for
08.00.33o
Trastuzumab (Herceptin®) and Related Biosimilars, Trastuzumab and Hyaluronidase-oysk (Herceptin Hylecta)
Show details for
08.00.25l
Treatment of Pulmonary Artery Hypertension with Intravenous, Subcutaneous, and Inhaled Pharmacologic Agents
08.00.57n
Treatments for Complex Regional Pain Syndrome (CRPS)
08.01.47a
Triamcinolone Acetonide Extended-Release Injectable (Zilretta™)
08.00.82k
Ustekinumab (Stelara®)
Show details for
08.01.18e
Vedolizumab (Entyvio®)
08.01.44c
Voretigene Neparvovec-rzyl (Luxturna™)